NYT vs PSO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

NYT

38.4
AI Score
VS
NYT Wins

PSO

35.8
AI Score

Investment Advisor Scores

NYT

38score
Recommendation
AVOID NEW MONEY

PSO

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric NYT PSO Winner
Forward P/E 21.097 18.018 PSO
PEG Ratio 3.7947 1.6831 PSO
Revenue Growth 11.3% 3.3% NYT
Earnings Growth 14.0% -2.9% NYT
Tradestie Score 38.4/100 35.8/100 NYT
Profit Margin 13.3% 8.8% NYT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED PSO

Relative Price Performance (Last 90 Days)

NYT 1M: +10.4% · 3M: -3.9% PSO 1M: +13.9% · 3M: +9.0%

Current Technical Phase

NYT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 59.8 · Price: $69.58

PSO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 75

RSI (14): 74.5 · Price: $18.24

Fundamentals Snapshot

Metric NYT PSO
Market Cap — —
Forward P/E 22.3 18.7
Trailing P/E 28.9 27.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% 0.5%
Operating Margin 0.2% 0.1%
EPS 2.40 0.67
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, NYT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.